Autolus Therapeutics plc
AUTL
$1.35
-$0.16-10.60%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -220.66M | -270.23M | -233.98M | -221.26M | -208.38M |
| Total Depreciation and Amortization | 7.72M | 7.41M | 6.86M | 6.47M | 6.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.33M | 66.52M | 80.10M | 71.12M | 55.94M |
| Change in Net Operating Assets | -23.66M | 3.13M | -9.59M | -9.00K | 292.00K |
| Cash from Operations | -206.27M | -193.17M | -156.62M | -143.68M | -145.59M |
| Capital Expenditure | -22.08M | -12.44M | -4.35M | -7.90M | -10.99M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -372.48M | -- | -- | -- | -- |
| Cash from Investing | -394.55M | -12.44M | -4.35M | -7.90M | -10.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 550.58M | 550.60M | 550.41M | 550.29M | 27.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 38.98M | 8.98M | 8.98M | 10.96M | -910.00K |
| Cash from Financing | 589.55M | 559.57M | 559.39M | 561.25M | -883.00K |
| Foreign Exchange rate Adjustments | -261.00K | 47.73M | 705.00K | 6.52M | 15.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.53M | 401.69M | 399.13M | 416.19M | -142.43M |
